Search consultations

Consultation

Consultation

Proposal For New Calcineurin Inhibitor Listings

NZNO warmly invites your feedback on PHARMAC’s proposal to list two new medicines on the Pharmaceutical Schedule with Special Authority restrictions and Hospital Indication restrictions.

As the Tender process is still in progress, the brand names, pricing and timing for these products to be listed is still to be determined; however, PHARMAC is seeking your feedback on the proposed restrictions for these products:

  • Pimecrolimus cream 1% for eczema (atopic dermatitis) on the eyelid
  • Tacrolimus ointment 0.1% for eczema (atopic dermatitis) on the face

Further information can be seen here.

Please note the short consultation timeframe.

If the Policy Team receives no feedback, NZNO will not make a submission.

Please send feedback to PolicyAnalysts@nzno.org.nz by 21 August 2020.

Notify me when this page changes

Enter your email address below to receive alerts when this page is updated.

Sign up below to receive an email when we update this page

Email:  
Captcha:
CAPTCHA image
Enter the code shown above in the box below.